Carrasquillo K G, Stanley A M, Aponte-Carro J C, De Jésus P, Costantino H R, Bosques C J, Griebenow K
University of Puerto Rico, Department of Chemistry, Río Piedras Campus, P.O. Box 23346, San Juan, Puerto Rico 00931-3346, USA.
J Control Release. 2001 Oct 19;76(3):199-208. doi: 10.1016/s0168-3659(01)00430-8.
Encapsulation of the model protein bovine serum albumin (BSA) into poly(D,L lactide-co-glycolide) (PLG) microspheres was performed by a non-aqueous oil-in-oil (o/o) methodology. Powder formulations of BSA obtained by spray-freeze drying were first suspended in methylene chloride containing PLG followed by coacervation by adding silicon oil and microsphere hardening in heptane. The secondary structure of BSA was determined at relevant steps of the encapsulation procedure by employing Fourier-transform infrared (FTIR) spectroscopy. This fast and non-invasive method demonstrated the potential to rapidly screen pharmaceutically relevant protein delivery systems for their suitability. Structural perturbations in BSA were reduced during the spray-freeze drying step by employing the excipient trehalose. The protein was then encapsulated into PLG microspheres under various conditions without inducing significant structural perturbations. BSA released from these microspheres had a similar monomer content as unencapsulated BSA and also the same secondary structure. Upon blending of a poloxamer (Pluronic F-68) with the polymer phase, in vitro release was characterized by a small initial release and a prolonged and continuous sustained phase. In conclusion, the developed o/o methodology coupled with FTIR spectroscopic monitoring of protein structure is a powerful approach for the development of sustained release microspheres.
采用非水油包油(o/o)方法将模型蛋白牛血清白蛋白(BSA)包封于聚(D,L-丙交酯-共-乙交酯)(PLG)微球中。通过喷雾冷冻干燥获得的BSA粉末制剂首先悬浮于含有PLG的二氯甲烷中,随后通过添加硅油进行凝聚,并在庚烷中使微球硬化。在包封过程的相关步骤中,采用傅里叶变换红外(FTIR)光谱法测定BSA的二级结构。这种快速且非侵入性的方法显示出快速筛选药学相关蛋白质递送系统适用性的潜力。在喷雾冷冻干燥步骤中,通过使用辅料海藻糖减少了BSA的结构扰动。然后在各种条件下将蛋白质包封于PLG微球中,而不引起明显的结构扰动。从这些微球中释放的BSA具有与未包封的BSA相似的单体含量以及相同的二级结构。当泊洛沙姆(普朗尼克F-68)与聚合物相混合时,体外释放的特征是初始释放量小且具有延长的持续释放阶段。总之,所开发的o/o方法与蛋白质结构的FTIR光谱监测相结合是开发缓释微球的有力方法。